KaiXinSan-JiaWei ameliorates cognitive dysfunction in APP/PS1 mice by intervening in gut microbiota and its metabolites DOI Creative Commons
Ludovica Mana, Fang Chen, Xiaoxia Yuan

et al.

Frontiers in Pharmacology, Journal Year: 2025, Volume and Issue: 16

Published: April 25, 2025

Alzheimer's disease (AD) is a degenerative of the central nervous system characterized by progressive cognitive impairment and memory loss. Chinese medicine's therapeutic effect on AD has become promising treatment option in recent years, herbal compound Kai Xin San-Jia Wei (KXSJW) one its representatives. This study employed comprehensive approach, including 16S rRNA Gaschromatography-mass spectrometry (GC-MS) analysis, to investigate efficacy intrinsic mechanism KXSJW AD. 50 3-month-old APPswe/PS1dE9 transgenic mice were randomly divided into 5 groups (n = 10): model group (M), donepezil (Don), KXSJW-low dose (KJW-L), KXSJW- medium (KJW-M), KXSJW-high (KJW-H), Ten C57BL/6 J wild-type selected as control (C). The administered saline gavage, was (0.92 mg/kg/d), KXSJW-low/medium/high extract (0.9/1.8/3.6 mL/kg/d); each treated once daily for 2 months. Morris Water Maze (MWM) evaluate learning abilities. Pathological changes colon tissue assessed through hematoxylin eosin (HE) staining. Analysis gut microbiota conducted using sequencing, microbial metabolite (short chain fatty acids, SCFAs) content detected GC-MS. Colonic barrier integrity examined immunohistochemistry western blot, while β-amyloid deposition brain assessed. ELISA used measure serum intestinal peptide hormones (Glucagon, GHRP-Ghrelin). enhanced ability memory, reduced amyloid mice. able restore balance flora regulate concentration metabolites, especially represented Firmicutes major butyric acid. Meanwhile, restored function improved release level GHRP-Ghrelin) indicates that can improve internal environment may homeostasis AD, with focus regulation microorganisms their subsequently Traditional Medicine (TCM) potential intervene multilevel interaction brain-gut-axis.

Language: Английский

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases DOI Creative Commons
Jian Sheng Loh, Wen Qi Mak, Li Tan

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2024, Volume and Issue: 9(1)

Published: Feb. 16, 2024

Abstract The human gastrointestinal tract is populated with a diverse microbial community. vast genetic and metabolic potential of the gut microbiome underpins its ubiquity in nearly every aspect biology, including health maintenance, development, aging, disease. advent new sequencing technologies culture-independent methods has allowed researchers to move beyond correlative studies toward mechanistic explorations shed light on microbiome–host interactions. Evidence unveiled bidirectional communication between central nervous system, referred as “microbiota–gut–brain axis”. microbiota–gut–brain axis represents an important regulator glial functions, making it actionable target ameliorate development progression neurodegenerative diseases. In this review, we discuss mechanisms As provides essential cues microglia, astrocytes, oligodendrocytes, examine communications microbiota these cells during healthy states Subsequently, diseases using metabolite-centric approach, while also examining role microbiota-related neurotransmitters hormones. Next, targeting intestinal barrier, blood–brain meninges, peripheral immune system counteract dysfunction neurodegeneration. Finally, conclude by assessing pre-clinical clinical evidence probiotics, prebiotics, fecal transplantation A thorough comprehension will foster effective therapeutic interventions for management

Language: Английский

Citations

274

The extraction, purification, structural features, bioactivities, and applications of Schisandra chinensis polysaccharides: A review DOI
Fei Luan, Junbo Zou, Xiaofei Zhang

et al.

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 262, P. 130030 - 130030

Published: Feb. 8, 2024

Language: Английский

Citations

18

Short-chain fatty acids: Important components of the gut-brain axis against AD DOI Open Access
Yan Huang,

Yi Feng Wang,

Jing Miao

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2024, Volume and Issue: 175, P. 116601 - 116601

Published: May 14, 2024

Alzheimer's disease (AD) comprises a group of neurodegenerative disorders with some changes in the brain, which could lead to deposition certain proteins and result degeneration death brain cells. Patients AD manifest primarily as cognitive decline, psychiatric symptoms, behavioural disorders. Short-chain fatty acids (SCFAs) are class saturated (SFAs) produced by gut microorganisms through fermentation dietary fibre ingested. SCFAs, significant mediator signalling, can have diverse physiological pathological roles gut-brain axis, play positive effect on via multiple pathways. Firstly, differences SCFAs microbial been stated cases humans mice this paper. And then, mechanisms three main treating summarized, well bacteria. Finally, functions played regulating intestinal flora homeostasis, modulating immune system, metabolic were considered be beneficial for treatment AD, elucidated, key bacteria pointed out. All all, paper provides an overview help people understand importance axis AD.

Language: Английский

Citations

18

Gut microbiota-host lipid crosstalk in Alzheimer’s disease: implications for disease progression and therapeutics DOI Creative Commons
Yaxi Luo,

Ling-Ling Yang,

Xiu‐Qing Yao

et al.

Molecular Neurodegeneration, Journal Year: 2024, Volume and Issue: 19(1)

Published: April 16, 2024

Abstract Trillions of intestinal bacteria in the human body undergo dynamic transformations response to physiological and pathological changes. Alterations their composition metabolites collectively contribute progression Alzheimer’s disease. The role gut microbiota disease is diverse complex, evidence suggests lipid metabolism may be one potential pathways. However, mechanisms that mediate pathology remain unclear, necessitating further investigation for clarification. This review highlights current understanding how disrupts discusses implications these discoveries guiding strategies prevention or treatment based on existing data.

Language: Английский

Citations

15

Microbial colony sequencing combined with metabolomics revealed the effects of chronic hexavalent chromium and nickel combined exposure on intestinal inflammation in mice DOI

Yueming Gu,

Shuangyan Zheng,

Cheng Huang

et al.

The Science of The Total Environment, Journal Year: 2024, Volume and Issue: 915, P. 169853 - 169853

Published: Jan. 11, 2024

Language: Английский

Citations

11

MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s Disease DOI Open Access
Ivana Raffaele, Serena Silvestro, Emanuela Mazzon

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(5), P. 4736 - 4736

Published: March 1, 2023

Alzheimer's disease (AD) is a neurodegenerative disorder known to be the leading cause of dementia worldwide. Many microRNAs (miRNAs) were found deregulated in brain or blood AD patients, suggesting possible key role different stages neurodegeneration. In particular, mitogen-activated protein kinases (MAPK) signaling can impaired by miRNA dysregulation during AD. Indeed, aberrant MAPK pathway may facilitate development amyloid-beta (Aβ) and Tau pathology, oxidative stress, neuroinflammation, cell death. The aim this review was describe molecular interactions between miRNAs MAPKs pathogenesis selecting evidence from experimental models. Publications ranging 2010 2023 considered, based on PubMed Web Science databases. According obtained data, several deregulations regulate conversely. Moreover, overexpressing silencing involved regulation seen improve cognitive deficits animal miR-132 particular interest due its neuroprotective functions inhibiting Aβ depositions, as well through ERK/MAPK1 modulation. However, further investigations are required confirm implement these promising results.

Language: Английский

Citations

21

Extraction, purification, structural characterization, and biological activity of polysaccharides from Schisandra chinensis: A review DOI
Rong Ji, Zhibin Wang, Haixue Kuang

et al.

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 271, P. 132590 - 132590

Published: May 22, 2024

Language: Английский

Citations

9

Along the microbiota–gut–brain axis: Use of plant polysaccharides to improve mental disorders DOI
Jiayu Gao, Ying Liang, Pu Liu

et al.

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 265, P. 130903 - 130903

Published: March 19, 2024

Language: Английский

Citations

8

Extraction, purification, structural characterization, and bioactivities of the genus Schisandra polysaccharides: A review DOI
Shujun Chen, Qin Fang, Ying Yang

et al.

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 262, P. 130257 - 130257

Published: Feb. 29, 2024

Language: Английский

Citations

7

Encapsulated lactiplantibacillus plantarum improves Alzheimer’s symptoms in APP/PS1 mice DOI Creative Commons
Fangfang Hu, Qian Gao, Caiyun Zheng

et al.

Journal of Nanobiotechnology, Journal Year: 2024, Volume and Issue: 22(1)

Published: Sept. 20, 2024

Language: Английский

Citations

7